HEALTH CARE:
PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
| Market Cap | 2.246 Billion | Shares Outstanding | 114.704 Million | Avg 30-day Volume | 1.74 Million |
| P/E Ratio | Dividend Yield | EPS | -2 | ||
| Price/Sales | 19700.8 | Price cash flow ratio | Price free cash flow ratio | -18.2 | |
| Book Value | -0.01 | Price to Tangible Book | -1066.02 | Alpha | 0.01 |
| Short Interest Ratio | % Short Interest to Float | R-squared | 0.163411 | ||
| BETA | 2.39847 | 52-week High/Low | 24.76 / 4.95 | Stddev | 0.255277 |
| Q1 2020 | All Institutions | Hedge Funds 1 |
|---|---|---|
| Filers who had this stock in their top 10: | 2 | 2 (0.13%) |
| 13F Filers holding this stock: | 146 | 50 (3.27%) |
| Aggregate 13F shares on 03/31/2020: | 63.842 Million | 43.486 Million |
| Aggregate 13F shares on 12/31/2019: | 58.196 Million | 38.601 Million |
| Percent change: | 9.70% | 12.66% |
| Funds creating new positions: | 36 | 14 |
| Funds Adding to an existing position: | 45 | 15 |
| Funds closing out their position: | 20 | 8 |
| Funds reducing their position: | 46 | 18 |
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
| TG Therapeutics Inc Chart by YCharts | |
| Yahoo! Finance | finviz |
| SEC Web Site | SEC DEF 14A Filings |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | |||||||||
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
